Preventive Effect of Neuromuscular Training on Chemotherapy-Induced Neuropathy: A Randomized Clinical Trial.

Nerve damage from chemotherapy drugs like oxaliplatin or vinca alkaloids is common, painful, and often forces doctors to reduce cancer treatment doses, which can affect survival. There are few proven ways to prevent it, so researchers tested whether structured exercise during chemotherapy could help. Patients were randomized to sensorimotor training, whole-body vibration training, or usual care, with supervised sessions twice a week alongside their cancer treatment.

Fewer patients in both exercise groups developed chemotherapy-induced nerve damage compared to those receiving usual care, with sensorimotor training showing the strongest effect, particularly in patients on vinca alkaloids. Secondary measures like balance, sensation, leg strength, and pain also favored sensorimotor training over usual care. This is described as initial evidence from a single multicenter trial with a modest number of participants, so while the findings are promising, they represent an early step rather than a settled answer for how nerve damage during chemotherapy might be prevented.

If you've had chemotherapy, you may know that some drugs can cause nerve damage in the hands and feet, leading to numbness, tingling, or pain that sometimes lasts long after treatment ends. This can be serious enough that doctors reduce chemo doses, which raises real questions about whether it affects how well the cancer treatment works.

This study looked at whether structured exercise programs done twice a week during chemotherapy could lower the chances of this nerve damage happening at all. Patients were split into three groups: one did balance and coordination exercises, another did vibration platform training, and the third received usual care without added exercise. Fewer people in both exercise groups developed nerve damage compared to those who didn't exercise, and the balance-focused training group showed the strongest results, along with better balance, sensation, and less pain in some cases. This was one trial with just over 150 patients, so it's an early but encouraging finding rather than definitive proof, and it doesn't tell us whether exercise programs work the same way for everyone or every chemotherapy drug.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This multicenter randomized controlled trial (STOP, n=158) compared sensorimotor training and whole-body vibration training against treatment as usual in patients receiving oxaliplatin or vinca alkaloids, with chemotherapy-induced peripheral neuropathy incidence as the primary endpoint. Intention-to-treat analysis showed significantly lower CIPN incidence in both intervention groups versus control (sensorimotor training 30.0%, whole-body vibration 41.2%, usual care 70.6%; P=.002 across strata), with effects more pronounced in the per-protocol analysis among patients completing over 75% of sessions.

Vinca alkaloid recipients performing sensorimotor training showed the greatest benefit, though direct statistical comparison between the two active interventions is not established by the abstract. Secondary outcomes favoring sensorimotor training over usual care included balance control across several testing conditions, vibration sensitivity, touch sensation, lower leg strength, pain reduction, burning sensation, chemotherapy dose reductions, and mortality, though effect sizes and confidence intervals for these secondary measures were not detailed in the abstract. With 158 randomized patients across three arms, this represents initial trial-level evidence rather than a robust or replicated body of research, and the five-year recruitment period with substantial screening attrition (1605 screened to 158 randomized) warrants consideration when judging generalizability.